PRESS RELEASE|January 06, 2026
SANVEEX ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE
text
About Sanveex
Sanveex is a global biopharmaceutical company dedicated to changing the lives of patients with severe diseases. We focus on scientific innovation to deliver transformative medicines across oncology and rare diseases.
Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements.